Sibiromycin is an aminoglycoside antibiotic produced by Streptosporangium sibiricum that also exhibits antitumour properties. It functions as an antineoplastic agent and a bacterial metabolite, belonging to the pyrrolobenzodiazepine class.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 12684-33-2
JQ1 compound
pharmaceutical raw material
Encorafenib
pharmaceutical raw material
Pyrotinib
pharmaceutical raw material
Hydroxycarbamide
pharmaceutical raw material
(6R,6aS)-2-[(2S,3R,4R,5S,6S)-3,4-dihydroxy-4,6-dimethyl-5-(methylamino)oxan-2-yl]oxy-4,6-dihydroxy-3-methyl-8-[(E)-prop-1-enyl]-5,6,6a,7-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-11-one
RAGFPHFDFVNLCG-INYQBOQCSA-N
C/C=C/C1=CN2[C@@H](C1)[C@H](NC3=C(C(=C(C=C3C2=O)O[C@H]4[C@@H]([C@]([C@H]([C@@H](O4)C)NC)(C)O)O)C)O)O